Hormone replacement therapy increases breast cancer risk
August 12th, 2010 - 1:04 am ICT by IANSLondon, Aug 11 (IANS) A new study has revealed that longer hormone replacement therapy (HRT) can dramatically increase women’s chances of developing breast cancer.
The research led by scientists in California has found that the risk was 83 percent greater for those using the oestrogen and progesterone combined pill for 15 or more years.
“This study confirms that risk is increased for women who are using HRT, but that it gradually returns to normal after stopping treatment,” express.co.uk quoted Dr Claire Knight, of Cancer Research UK, as saying.
The study is the latest in a string of conflicting reports.
John Stevenson, a HRT expert at London’s Royal Brompton Hospital, said: “The risk is less than that seen with so many physical and lifestyle factors.
“So women should not be put off taking HRT for any length of time if they need it.”
- Hormone replacement therapy tied to breast cancer - Dec 30, 2011
- How HRT and the Pill can lead to breast cancer - Sep 30, 2010
- Withdrawing HRT from women cuts breast cancer risk, shows study - Sep 24, 2010
- Stopping hormone replacement cuts breast cancer risk - Sep 24, 2010
- 10 tips to steer clear of breast cancer - Oct 03, 2010
- Oestrogen therapy 'causes ovarian cancer to grow five times faster' - Oct 21, 2010
- Starting hormone therapy at menopause 'ups breast cancer risk' - Jan 29, 2011
- Estrogen alone can cut risk of breast cancer - Dec 10, 2010
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
- Avoidable breast cancer risk factors identified - Jan 19, 2011
- HRT raises risk of kidney stones - Oct 13, 2010
- Side effects that are actually beneficial for you - Dec 15, 2010
- Hormone replacement therapy 'increases lung cancer risk' - Mar 04, 2010
- Hormone-replacement therapy 'ups risk of dying from lung cancer' - Sep 20, 2009
- Low-dose HRT skin patches 'safer than tablets' - Jun 04, 2010
Tags: breast cancer, breast cancer risk, cancer research uk, combined pill, conflicting reports, dr claire, express co, hormone replacement therapy, hrt, john stevenson, length of time, lifestyle factors, london, oestrogen, progesterone, royal brompton hospital, scientists